Brind.

Soligenix announced that its drug candidate SGX945 showed efficacy similar to apremilast, leading to a stock surge reported by Benzinga.

1 report, 1 independent Updated Jul 31

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Soligenix (United States)Amgen Benzinga

Keep exploring

The entities involved

Soligenix (United States)
company in Princeton, United States

Nothing else this week.
Amgen
American multinational biopharmaceutical company
- Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
- Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05
Benzinga
American news channel
- Benzinga reported on the recent stock price activity of SpaceX.Mon 02:14
- Benzinga reported analyst expectations for Jabil.Mon 02:08

Related events

Joint drug trial success boosts Amgen stock.Sep 9

Coverage

Newest first; wire copies grouped

Jul 31BenzingaSoligenix Drug Matches FDA-Approved Amgen Therapy In Rare Disease Trial Soligenix Inc. (NASDAQ:SNGX) shares surged on Thursday as the company announced positive results from its Phase 2a proof-of-con